Form D · Biotechnology
Aurora Biopharma, Inc.
Cambridge, MA · CIK 0001691940
Offering snapshot reported Dec 29, 2016 · SEC filing
- Reported sold
- $100K Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 19, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2016 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Dec 29, 2016 | Initial | $340,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-277341
Convertible promissory note with shares issuable upon conversion.
Source: Form D, filed Dec 29, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Brooks | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Harvard Square, One Mifflin Place Suite 400
Cambridge, MA, 02138
Cambridge, MA, 02138